The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q3 2023 call → NOWe need to determine if management conveys that the reported results do not represent the business actually running today. The key is whether management indicates a gap between the reported period and the current state, with concrete actions or changes already in place. In the transcript, management discusses: - Launch of updated vaccine in U.S. in mid-October, which is after Q3 ended. So Q3 results don't include this launch. - They mention that they are "three weeks into our season launch" and have secured broad access, but early data. - They also discuss restructuring and cost reductions, with plans to further reduce costs in 2024, but that's future. - They emphasize that the current season is transitional and that they are focusing on future opportunities like combination vaccine. But does management explicitly say that the reported Q3 numbers do not reflect the current business? They do mention that the launch started after the quarter, so Q3 revenue was low. They also mention that they are ahead of cost reduction targets. However, the overall tone is more about guidance for the future and current market conditions. The question asks: "does management repeatedly or substantially indicate that the just-reported numbers describe a company that has already been left behind by what is now actually happening inside the business?" Management does say that the U.S. launch began in mid-October, after Q3, so Q3 results don't include that. They also say that they are seeing early indicators of uptake. But they also acknowledge that the market is uncertain and they are adjusting guidance. They are not saying that the business has fundamentally changed; they are saying that the season is early and they are in a transition. They also discuss cost reductions that are already implemented and more planned. But that's about future efficiency. I think the key is whether they convey that the reported period is stale relative to the operating present. They do mention that the launch is new and that they have already achieved certain things. For example, they say "we've demonstrated our ability to update our COVID-19 vaccine with seasonal strain changes" and "we are focused on commercial execution." They also say "we are prepared to initiate additional cost reductions" which is future.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.